Emma Hatfield Sapp
Overview
Explore the profile of Emma Hatfield Sapp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eid W, Sapp E, Conroy C, Bessinger C, Moody C, Yadav R, et al.
Am J Prev Cardiol
. 2024 Dec;
21:100895.
PMID: 39720768
Background: Lipoprotein(a) [Lp(a)] is a low-density lipoprotein variant with atherogenic, thrombogenic, and pro-inflammatory properties that may have numerous pathologic effects, including dyslipidemia. Screening for Lp(a) is clinically significant, due to...
2.
Eid W, Sapp E, Wendt A, Lumpp A, Miller C
J Clin Endocrinol Metab
. 2021 Dec;
107(4):1078-1090.
PMID: 34871430
Context: Familial hypercholesterolemia (FH) confers a greatly increased risk for premature cardiovascular disease, but remains very underdiagnosed and undertreated in primary care populations. Objective: We assessed whether using a hybrid...
3.
Eid W, Sapp E, Flerlage E, Nolan J
J Am Heart Assoc
. 2021 Sep;
10(17):e020800.
PMID: 34465130
Background Although severe hypercholesterolemia confers a 5-fold increased long-term risk for coronary artery disease, treatment guidelines may not be fully implemented, leading to underdiagnosis and suboptimal treatment. To further understand...
4.
Eid W, Sapp E, McCreless T, Nolan J, Flerlage E
Am J Cardiol
. 2020 Aug;
132:59-65.
PMID: 32773228
Severe hypercholesterolemia (SH) includes individuals with LDL-C ≥ 190 mg/dl, regardless of cause. These individuals have a fivefold increased long-term risk for coronary artery disease. Although systematic SH screening can...